| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Syndax Pharmaceuticals, Inc. (SNDX) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. SNDX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.8K | $9.45M | -6,847 | |
| CFO | 139.3K | $2.72M | -1,177 | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | Ordentlich Peter66 | Chief Scientific Officer | Sale+OE | 25,000 | $25.04 | $626,024.60 | -96.9% | -3.8% | -33.9% | |
| Oct 6, 2022 | Metzger Michael A52 | Chief Executive Officer | Sale+OE | 16,231 | $25.29 | $410,507.96 | -47.9% | -5.1% | -51.4% | |
| Oct 6, 2022 | Katkin Keith65 | Director | Sale+OE | 29,899 | $25.90 | $774,411.01 | -31.8% | -5.1% | -51.4% | |
| Oct 4, 2022 | Katkin Keith65 | Director | Sale+OE | 4,101 | $25.06 | $102,776.76 | -2.1% | +2.6% | -51.3% | |
| Oct 4, 2022 | Metzger Michael A52 | Chief Executive Officer | Sale+OE | 33,769 | $25.02 | $844,890.00 | -38.9% | +2.6% | -51.3% | |
| Sep 20, 2022 | Morrison Briggs61 | President, Head Of R&D | Sale+OE | 173,988 | $23.11 | $4,020,056.46 | -83.0% | -1.2% | -31.1% | |
| Sep 16, 2022 | Podlesak Dennis62 | Director | Sale+OE | 78,815 | $24.08 | $1,897,987.53 | -25.7% | +4.6% | -25.0% | |
| Sep 16, 2022 | Morrison Briggs61 | President, Head Of R&D | Sale+OE | 279,420 | $23.64 | $6,604,327.22 | -79.7% | +4.6% | -25.0% | |
| Aug 24, 2022 | Ordentlich Peter66 | Chief Scientific Officer | Sale+OE | 25,000 | $25.04 | $625,892.50 | -97.9% | -9.6% | -26.8% | |
| Aug 5, 2022 | Legault Pierre61 | Director | Sale+OE | 24,000 | $23.02 | $552,381.60 | -27.3% | -6.5% | -17.2% |